Pharmaceuticals and Medical Devices Agency Deliberative Council, Medical Devices and In Vitro Diagnostics Subcommittee Meeting Held

This news of the Pharmaceutical Affairs and Food Sanitation Council meeting suggests developments concerning the approval and review processes for medical devices and in vitro diagnostics, which are fundamental to healthcare provision.This not only indicates the potential emergence of new medical technologies and diagnostic agents in the market but also directly relates to the management strategies of medical institutions regarding which medical devices and diagnostic agents they will introduce in the future and which medical departments they will strengthen. Especially for medical institution managers considering future M&A or business succession,understanding the latest medical technology trends serves as a basis for enhancing the attractiveness of a medical institution as a target for acquisition or for deciding which medical institution to select as a successor.

The discussions in the Subcommittee on Medical Devices and In Vitro Diagnostics suggest the direction of technologies and devices that medical institutions will acquire and introduce in the future, which is also a crucial factor in evaluating the business value of medical institutions.For example, medical institutions equipped with facilities capable of handling new diagnostic technologies may receive higher valuations in the M&A market from the perspective of future profitability and specialization. For medical institution managers facing succession issues,this will serve as an opportunity to consider specific strategies, such as which medical devices and diagnostic agents their institution should strategically introduce going forward, or whether to consider business succession through M&A from the viewpoint of adaptability to the latest technologies.